Guess?, Inc. Announces Participation at the ICR Conference 2024
LOS ANGELES–(BUSINESS WIRE)–Guess?, Inc. (NYSE: GES) announced today that the Company will be participating in a fireside chat at the ICR Conference... Read more.
Six Nuveen Closed-End Funds Announce Availability of 19(a) Notices
NEW YORK–(BUSINESS WIRE)–The 19(a) distribution notices for six Nuveen closed-end funds are now available. These informational notices provide further... Read more.
Li-Cycle Receives Continued Listing Standard Notice from NYSE
TORONTO–(BUSINESS WIRE)–Li-Cycle Holdings Corp. (NYSE: LICY) (“Li-Cycle” or the “Company”), a leading global lithium-ion battery resource recovery... Read more.
First Trust Enhanced Equity Income Fund Issues Notice Regarding December 2023 Distribution
WHEATON, Ill.–(BUSINESS WIRE)–The Board of Trustees of First Trust Enhanced Equity Income Fund (the “Fund”) (NYSE: FFA), CUSIP 337318109,... Read more.
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment... Read more.
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment... Read more.
Fourshore Partners Announces Acquisition of Power Funding
MIAMI–(BUSINESS WIRE)–Fourshore Partners (Fourshore) announced today its acquisition of Power Funding (“Power”; “Company”), a premier factoring... Read more.
State Fund Declaring 10% Dividend for 2023 Policy Year
Approximately $102 million will be returned to California businesses SACRAMENTO, Calif.–(BUSINESS WIRE)–#2023dividends—State Compensation Insurance... Read more.
Browning West Issues Letter to Gildan Activewear Shareholders Announcing Intent to Requisition Special Meeting to Reconstitute Board of Directors
Special Meeting Would Empower Shareholders to Improve Gildan’s Board by Voting to Replace Five Incumbent Directors Replacement Slate Includes Five High Quality... Read more.
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Eagle Pharmaceuticals, Inc. (EGRX) Investors and Encourages Investors to Contact the Firm Before February 9, 2024
NEW YORK–(BUSINESS WIRE)–$EGRX #classactionlawsuit–The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in... Read more.